Factors influencing oncologists’ decisions for germline BRCA testing and adjuvant therapy selection in HER2-negative early breast cancer
- DOI
- 10.3389/fonc.2026.1854965
- Published
- 2026-09-03
- Container
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2026.1854965,
title = {Factors influencing oncologists’ decisions for germline BRCA testing and adjuvant therapy selection in HER2-negative early breast cancer},
author = {Qixin Li and M. Janelle Cambron-Mellott and Xiaoqing Xu and Nicole Kashine-Tack and Jennifer F. Hayes and Kathryn Emily Mishkin and Alexandra Gordon and Oliver Will and Lauren A. Howell and Alejandro Noval and Kathleen Beusterien},
year = {2026},
journal = {Frontiers in Oncology},
doi = {10.3389/fonc.2026.1854965},
url = {https://doi.org/10.3389/fonc.2026.1854965}
}RIS
TY - JOUR TI - Factors influencing oncologists’ decisions for germline BRCA testing and adjuvant therapy selection in HER2-negative early breast cancer AU - Qixin Li AU - M. Janelle Cambron-Mellott AU - Xiaoqing Xu AU - Nicole Kashine-Tack AU - Jennifer F. Hayes AU - Kathryn Emily Mishkin AU - Alexandra Gordon AU - Oliver Will AU - Lauren A. Howell AU - Alejandro Noval AU - Kathleen Beusterien PY - 2026 JO - Frontiers in Oncology DO - 10.3389/fonc.2026.1854965 UR - https://doi.org/10.3389/fonc.2026.1854965 ER -
APA
Li, Q., Cambron-Mellott, M. J., Xu, X., Kashine-Tack, N., Hayes, J. F., Mishkin, K. E., Gordon, A., Will, O., Howell, L. A., Noval, A., & Beusterien, K. (2026). Factors influencing oncologists’ decisions for germline BRCA testing and adjuvant therapy selection in HER2-negative early breast cancer. Frontiers in Oncology. https://doi.org/10.3389/fonc.2026.1854965
Source records
- crossref · retrieved 2026-09-26T02:56:59.307Z